HUMDF (Hua Medicine) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine ROE % Adjusted to Book Value?

Hua Medicine's ROE % for the quarter that ended in Dec. 2024 was 0.00%. Hua Medicine's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Hua Medicine's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.

Hua Medicine ROE % Adjusted to Book Value Historical Data

The historical data trend for Hua Medicine's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hua Medicine ROE % Adjusted to Book Value Chart

Hua Medicine Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-5.84

-4.80

-7.52

Hua Medicine Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial												-5.44	-10.76	-10.82	-	-

Competitive Comparison of Hua Medicine's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Hua Medicine's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hua Medicine's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hua Medicine's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Hua Medicine's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Hua Medicine ROE % Adjusted to Book Value Calculation

Hua Medicine's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Hua Medicine's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Hua Medicine ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Hua Medicine's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Hua Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (OTCPK:HUMDF) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

02552:Hong Kong

Address

Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203

Website

https://www.huamedicine.com

Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.